Carvedilol (Page 9 of 9)

Package/Label Display Panel

NDC 68462-162-01
CARVEDILOL
TABLETS USP
3.125 mg-100 Tablets

LBL3.125mg100.jpg
(click image for full-size original)

Package/Label Display Panel

NDC 68462-163-01
CARVEDILOL
TABLETS USP 6.25 mg-100 Tablets

LBL6.25mg100.jpg
(click image for full-size original)


NDC 68462-164-01
CARVEDILOL
TABLETS USP 12.5 mg100 Tablets

LBL12.5mg100.jpg
(click image for full-size original)

NDC 68462-165-01
CARVEDILOL
TABLETS USP 25 mg100 Tablets

LBL25mg100.jpg
(click image for full-size original)
CARVEDILOL carvedilol tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-162
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CARVEDILOL (CARVEDILOL) CARVEDILOL 3.125 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
POVIDONE, UNSPECIFIED
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 5mm
Flavor Imprint Code G
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-162-60 60 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68462-162-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68462-162-18 180 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68462-162-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68462-162-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078251 09/05/2007
CARVEDILOL carvedilol tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-163
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CARVEDILOL (CARVEDILOL) CARVEDILOL 6.25 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
POVIDONE, UNSPECIFIED
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 6mm
Flavor Imprint Code G;41
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-163-60 60 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68462-163-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68462-163-18 180 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68462-163-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68462-163-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078251 09/05/2007
CARVEDILOL carvedilol tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-164
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CARVEDILOL (CARVEDILOL) CARVEDILOL 12.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
POVIDONE, UNSPECIFIED
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape OVAL (capsule shaped) Size 10mm
Flavor Imprint Code G;164
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-164-60 60 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68462-164-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68462-164-18 180 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68462-164-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68462-164-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078251 09/05/2007
CARVEDILOL carvedilol tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68462-165
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CARVEDILOL (CARVEDILOL) CARVEDILOL 25 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CROSPOVIDONE (15 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
POVIDONE, UNSPECIFIED
TITANIUM DIOXIDE
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 10mm
Flavor Imprint Code G41;25
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68462-165-60 60 TABLET, FILM COATED in 1 BOTTLE None
2 NDC:68462-165-01 100 TABLET, FILM COATED in 1 BOTTLE None
3 NDC:68462-165-18 180 TABLET, FILM COATED in 1 BOTTLE None
4 NDC:68462-165-05 500 TABLET, FILM COATED in 1 BOTTLE None
5 NDC:68462-165-10 1000 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078251 09/05/2007
Labeler — Glenmark Pharmaceuticals Inc., USA (130597813)
Establishment
Name Address ID/FEI Operations
Glenmark Pharmaceuticals Limited 677318665 ANALYSIS (68462-162), ANALYSIS (68462-163), ANALYSIS (68462-164), ANALYSIS (68462-165), MANUFACTURE (68462-162), MANUFACTURE (68462-163), MANUFACTURE (68462-164), MANUFACTURE (68462-165)
Establishment
Name Address ID/FEI Operations
Glenmark Pharmaceuticals Limited 862603186 ANALYSIS (68462-162), ANALYSIS (68462-163), ANALYSIS (68462-164), ANALYSIS (68462-165), MANUFACTURE (68462-162), MANUFACTURE (68462-163), MANUFACTURE (68462-164), MANUFACTURE (68462-165)

Revised: 09/2019 Glenmark Pharmaceuticals Inc., USA

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.